What happened Thermo Fisher Scientific Inc. (NYSE: TMO) said third-quarter revenue rose 9% to $12.14 billion on October 21, 2026. Organic revenue growth was 6%. GAAP diluted EPS rose 9% to $4.64, and adjusted EPS rose 15% to $6.68. GAAP operating income rose 17% to $2.26 billion, and adjusted operating income rose 15% to $2.97 […]